Comments on: IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer

Comments on: IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer https://9krapalm.com/igcs-late-breaking-abstract-and-the-lancet-akeso-published-positive-pfs-and-os-results-from-phase-3-first-line-study-of-cadonilimab-in-cervical-cancer/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Wed, 16 Oct 2024 11:49:30 +0000 hourly 1 https://wordpress.org/?v=7.0